Garrison Point Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Sell
3,770
-1,180
-24% -$136K 0.18% 118
2026
Q1
$592K Hold
4,950
0.27% 97
2025
Q4
$674K Sell
4,950
-150
-3% -$21.6K 0.3% 86
2025
Q3
$752K Sell
5,100
-190
-4% -$26.4K 0.32% 80
2025
Q2
$684K Sell
5,290
-150
-3% -$18.2K 0.31% 82
2025
Q1
$650K Sell
5,440
-125
-2% -$15.5K 0.32% 80
2024
Q4
$646K Buy
5,565
+115
+2% +$14.5K 0.31% 84
2024
Q3
$736K Buy
5,450
+155
+3% +$20.7K 0.46% 65
2024
Q2
$718K Buy
5,295
+415
+9% +$56.5K 0.47% 65
2024
Q1
$631K Buy
4,880
+530
+12% +$64K 0.41% 76
2023
Q4
$497K Buy
4,350
+600
+16% +$59.9K 0.35% 90
2023
Q3
$341K Buy
3,750
+325
+9% +$33.5K 0.26% 104
2023
Q2
$386K Buy
+3,425
New +$362K 0.28% 102

Other funds holding XYL

Garrison Point Advisors's XYL Position: Q2 2026 in Review

Garrison Point Advisors reduced its Xylem (XYL) stake by 24% in Q2 2026, selling an estimated $136K and leaving 3,770 shares worth $446K. The position accounts for 0.18% of the portfolio, ranked #118.

Garrison Point Advisors first reported a position in XYL in Q2 2023 and has held it in 13 quarters since. The position peaked at $752K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Garrison Point Advisors held 3,770 shares of Xylem worth $446K as of Q2 2026.
  • Garrison Point Advisors sold 1,180 Xylem shares in Q2 2026, an estimated $136K.
  • Xylem made up 0.18% of Garrison Point Advisors's portfolio in Q2 2026, its #118 holding.
  • Garrison Point Advisors first reported a position in Xylem in Q2 2023 and has held it in 13 quarters since.
  • Garrison Point Advisors's Xylem position peaked at $752K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.